Viridian Therapeutics, Inc.
VRDN
$30.43
-$1.02-3.24%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.86% | -11.51% | -11.28% | -4.73% | 31.83% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.47% | -25.29% | -1.30% | 48.03% | 36.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.18% | -11.94% | -11.00% | -3.77% | 31.92% |
|
|
|||||
| Total Current Assets | -1.18% | -11.94% | -11.00% | -3.77% | 31.92% |
| Net Property, Plant & Equipment | 20.83% | -5.72% | -5.43% | -6.75% | 10.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 200.00% | 3.48% | -2.40% | -41.27% | 29.44% |
| Total Assets | -0.89% | -11.90% | -10.97% | -3.82% | 31.80% |
|
|
|||||
| Total Accounts Payable | 18.14% | 119.20% | 81.33% | -66.19% | 101.85% |
| Total Accrued Expenses | 13.62% | 20.31% | -35.50% | 31.66% | 14.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -91.88% | 1,576.87% | 4.48% | -12.90% | -83.03% |
| Total Finance Division Other Current Liabilities | 29.17% | -25.77% | 0.00% | 0.00% | 0.00% |
| Total Other Current Liabilities | 29.17% | -25.77% | 0.00% | 0.00% | 0.00% |
| Total Current Liabilities | -3.59% | 55.91% | -29.55% | 15.74% | 12.52% |
|
|
|||||
| Total Current Liabilities | -3.59% | 55.91% | -29.55% | 15.74% | 12.52% |
| Long-Term Debt | 69.11% | -40.28% | 0.50% | 0.29% | 17.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 48.39% | -7.64% | -6.92% | -6.34% | 31.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 125.00% | -25.35% | -20.22% | -17.02% |
| Total Liabilities | 10.44% | 18.84% | -20.15% | 9.88% | 14.34% |
|
|
|||||
| Common Stock & APIC | 1.46% | 0.77% | 1.32% | 3.13% | 22.59% |
| Retained Earnings | -2.92% | -9.30% | -8.73% | -8.70% | -9.14% |
| Treasury Stock & Other | 426.09% | -71.84% | 2,550.00% | -101.07% | 271.64% |
| Total Common Equity | -3.74% | -21.49% | -13.91% | -6.91% | 57.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | -5.42% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -5.42% |
|
|
|||||
| Total Common Equity | -3.74% | -21.49% | -13.91% | -6.91% | 57.33% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -5.42% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.37% | -14.77% | -10.00% | -5.07% | 33.66% |
|
|
|||||